IMC Chicago’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-93,825
Closed -$1.45M 6852
2026
Q1
$1.27M Buy
93,825
+22,472
+31% +$314K ﹤0.01% 3032
2025
Q4
$888K Buy
71,353
+30,214
+73% +$326K ﹤0.01% 3072
2025
Q3
$407K Sell
41,139
-15,135
-27% -$147K ﹤0.01% 3290
2025
Q2
$503K Buy
56,274
+29,561
+111% +$250K ﹤0.01% 2865
2025
Q1
$233K Buy
+26,713
New +$280K ﹤0.01% 3013
2023
Q1
Sell
-142,415
Closed -$1.58M 1400
2022
Q4
$1.59M Buy
142,415
+92,409
+185% +$966K ﹤0.01% 886
2022
Q3
$426K Buy
+50,006
New +$492K ﹤0.01% 1104
2021
Q1
Sell
-21,476
Closed -$402K 1195
2020
Q4
$402K Buy
21,476
+6,046
+39% +$98.6K ﹤0.01% 977
2020
Q3
$229K Buy
+15,430
New +$246K ﹤0.01% 924
2019
Q3
Sell
-14,322
Closed -$281K 807
2019
Q2
$273K Buy
+14,322
New +$317K ﹤0.01% 682

Other funds holding VTRS

IMC Chicago's VTRS Position: Q2 2026 in Review

IMC Chicago sold out of Viatris (VTRS) in Q2 2026, closing a stake of 93,825 shares — an estimated $1.45M sold.

IMC Chicago first reported a position in VTRS in Q2 2019 and held it in 10 quarters. The position peaked at $1.59M in Q4 2022. 611 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • IMC Chicago reported no remaining Viatris position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 93,825 Viatris shares in Q2 2026, an estimated $1.45M.
  • IMC Chicago first reported a position in Viatris in Q2 2019 and held it in 10 quarters.
  • IMC Chicago's Viatris position peaked at $1.59M in Q4 2022.
  • 611 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.